ClearPoint Neuro, Inc. Announces First-in-Human Cases of

$ 6.00

4.7 (365) In stock

SOLANA BEACH, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling company providing

vygr-20201231x10k007.jpg

ClearPoint Neuro (Nasdaq:CLPT) - Stock Price, News & Analysis

Our History

Clark Chen's Instagram, Twitter & Facebook on IDCrawl

BIBA Publishing, Author at NeuroNews International

Blackrock Neurotech's MoveAgain brain interface gets FDA breakthrough device designation; Commercialization planned for 2022 : r/neuralcode

form10-k_005.jpg

Webinars & Presentations

ClearPoint Neuro reports Q4 and full-year 2023 results - Medical Buyer

ClearPoint's (CLPT) Prism System Favored by Latest Study

Intrommune extends scope of Phase 1 peanut allergy trial

Related products

Paper Mate® Clear Point Mechanical Pencils with Tube of Lead/Erasers, 0.7 mm, HB (#2), Black Lead, Randomly Assorted Barrel Colors, 2/PK

Paper Mate ClearPoint Elite 0.7mm Mechanical Pencils, Blue Barrel Pack of 3

Does Clearpoint Direct accept Bitcoin or cryptocurrency? — Knoji

Apartment for Sale in Clearpoint: Direct from Developer, 10%DP

$35 for a Chef's Kitchen 20-Piece Stainless Steel BBQ Set from